Hudson Technologies Inc

Hudson Technologies Inc maintains a strong liquidity position, with a current ratio of 3.26, indicating the company can cover its short-term liabilities more than three times over. The company's liquidity is further supported by $39.46 million in cash and equivalents, despite a negative operating cash flow of -$3.16 million. The absence of long-term debt and a debt-to-equity ratio of 0.0 suggest a conservative capital structure with minimal leverage risk. Profitability metrics show a return on equity (ROE) of 6.85% and a return on assets (ROA) of 5.23%, which are below the industry median for Electrical Components & Equipment firms. The company's net income of $16.67 million on $246.61 million in revenue yields a net margin of 6.76%, which is in line with the industry median. However, the gross profit margin of 25.18% is slightly above the median, indicating efficient cost control in production. The company's revenue is concentrated in the Industrial Goods sector, with no disclosed geographic diversification in the latest financial data. This concentration may expose the company to sector-specific risks, such as demand fluctuations in industrial manufacturing. Looking ahead, the company is projected to grow revenue by 10.5% in the current fiscal year and 12.3% in the next fiscal year, based on analyst estimates and historical performance. The mean price target of $9.00 implies a potential 86% upside from the current market price of $4.84. The risk assessment indicates low liquidity and dilution risk, with no immediate filing-based flags detected. The company's dilution potential is also low, as the basic and diluted shares outstanding are identical at 42.07 million, and no recent equity issuance or ATM/shelf disclosures were identified. Recent events include the release of the latest financial data, which shows a free cash flow of $17.62 million despite a capital expenditure of -$5.05 million. The company's operating cash flow remains a concern, with a negative value of -$3.16 million, which may require monitoring in future periods.